Our findings revealed that the immune landscape varied in mice exhibiting different histopathological stages, and we demonstrated that removal of programmed cell death-ligand 1 (PD-L1) signaling from the beginning effectively activated the anti-tumor immune response and prolonged survival time in PDAC-developing mice. Here, CD274 is linked to neoplasm.